| [1] |
何仲琴.胰岛素样生长因子1在老年非小细胞肺癌患者外周血中的改变及临床意义[J].临床和实验医学杂志, 2016, 15(14): 1401-1404.
|
| [2] |
邹晓岚,叶茸茸,王洋,等.胰岛素样生长因子-1及其受体在肿瘤中的研究进展[J].重庆医学, 2018, 47(18): 2474-2476, 2479.
|
| [3] |
顾玉彬.肾癌组织中转录因子E2相关因子2和膜岛素样生长因子-1的表达[J].肿瘤基础与临床, 2016, 29(3): 198-200.
|
| [4] |
曹友红,许春芳.胰岛素样生长因子-1受体在恶性肿瘤中的研究进展[J].现代肿瘤医学, 2015, 23(5): 706-709.
|
| [5] |
章菊,叶书来,董行,等.血清IGF-Ⅰ和IGFPB-3检测在不同类型脑肿瘤中的应用[J].临床输血与检验, 2017, 19(5): 475-478.
|
| [6] |
李毅芳,李凌,蔡燕芝,等.奥曲肽序贯溴隐亭对GH型垂体瘤伴海绵窦侵袭的疗效[J].热带医学杂志, 2018, 18(7): 963-967.
|
| [7] |
Daughaday WH, Salmon WD Jr, Alexander F. Sulfation factor activity of sera from patients with pituitary disorders[J]. J Clin Endocrinol Metab, 1959, 19(7): 743-758.
|
| [8] |
Troncoso R, Ibarra C, Vicencio JM, et al. New insights into IGF-1 signaling in the heart[J]. Trends Endocrinol Metab, 2014, 25(3): 128-137.
|
| [9] |
Losa M, Bollerslev J. Pros and cons in endocrine practice: pre-surgical treatment with somatostatin analogues in acromegaly[J]. Endocrine, 2016, 52(3): 451-457.
|
| [10] |
Wolfe A, Divall S, Wu S. The regulation of reproductive neuroendocrine function by insulin and insulin-like growth factor-1 (IGF-1)[J]. Front Neuroendocrinol, 2014, 35(4): 558-572.
|
| [11] |
Caban M, Owczarek K, Chojnacka K, et al. Overview of polyphenols and polyphenol-rich extracts as modulators of IGF-1, IGF-1R, and IGFBP expression in cancer diseases[J]. J Funct Foods, 2019, 52: 389-407.
|
| [12] |
Murekatete B, Shokoohmand A, McGovern J, et al. Targeting insulin-like growth factor-I and extracellular matrix interactions in melanoma progression[J]. Sci Rep, 2018, 8(1): 583.
|
| [13] |
Wang Y, Wang W, Li D, et al. IGF-1 alleviates NMDA-induced excitotoxicity in cultured hippocampal neurons against autophagy via the NR2B/PI3K-AKT-mTOR pathway[J]. J Cell Physiol, 2014, 229(11): 1618-1629.
|
| [14] |
李旭,姚智.不同类型脑肿瘤患者血清胰岛素样生长因子-Ⅰ检测的临床意义[J].中国全科医学, 2011, 14(23): 2687-2688.
|
| [15] |
Giovannone B, Scaldaferri ML, Federici M, et al. Insulin receptor substrate (IRS) transduction system: distinct and overlapping signaling potential[J]. Diabetes Metab Res Rev, 2000, 16(6): 434-441.
|
| [16] |
Crino PB. The mTOR signalling cascade: paving new roads to cure neurological disease[J]. Nat Rev Neurol, 2016, 12(7): 379-392.
|
| [17] |
Zhou Y, Geng P, Liu Y, et al. Rotavirus-encoded virus-like small RNA triggers autophagy by targeting IGF1R via the PI3K/Akt/mTOR pathway[J]. Biochim Biophys Acta Mol Basis Dis, 2018, 1864(1): 60-68.
|
| [18] |
Tsai JL, Lee YM, Pan CY, et al. The novel VEGF121-VEGF165 fusion attenuates angiogenesis and drug resistance via targeting VEGFR2-HIF-1α-VEGF165/lon signaling through PI3K-AKT-mTOR pathway[J]. Curr Cancer Drug Targets, 2016, 16(3): 275-286.
|
| [19] |
Dobolyi A, Lékó AH. The insulin-like growth factor-1 system in the adult mammalian brain and its implications in central maternal adaptation[J]. Front Neuroendocrinol, 2019, 52: 181-194.
|
| [20] |
Day PF, Loto MG, Glerean M, et al. Incidence and prevalence of clinically relevant pituitary adenomas: retrospective cohort study in a health management organization in Buenos Aires, Argentina[J]. Arch Endocrinol Metab, 2016, 60(6): 554-561.
|
| [21] |
Hirohata T, Ishii Y, Matsuno A. Treatment of pituitary carcinomas and atypical pituitary adenomas: a review[J]. Neurol Med Chir (Tokyo), 2014, 54(12): 966-973.
|
| [22] |
蒋霞,蒋晶,虞培娟,等.不同类型脑肿瘤患者血清胰岛素样生长因子对比研究[J].中国实用神经疾病杂志, 2016, 19(17): 66-67.
|
| [23] |
Werner H, LeRoith D. Insulin and insulin-like growth factor receptors in the brain: physiological and pathological aspects[J]. Eur Neuropsychopharmacol, 2014, 24(12): 1947-1953.
|
| [24] |
Bake S, Selvamani A, Cherry J, et al. Blood brain barrier and neuroinflammation are critical targets of IGF-1-mediated neuroprotection in stroke for middle-aged female rats[J]. PLoS One, 2014, 9(3): e91427.
|
| [25] |
薛胜祥.不同类型脑肿瘤患者血清IGF-Ⅰ表达水平的研究[J].中华神经外科疾病研究杂志, 2014, 13(6): 544.
|
| [26] |
马瑞敏,贾子琪,康熙雄,等.血清生长激素与胰岛素样生长因子1水平对脑部肿瘤鉴别诊断价值的探讨[J].检验医学与临床, 2017, 14(23): 3435-3437.
|
| [27] |
D’Ercole AJ, Stiles AD, Underwood LE. Tissue concentrations of somatomedin C: further evidence for multiple sites of synthesis and paracrine or autocrine mechanisms of action[J]. Proc Natl Acad Sci U S A, 1984, 81(3): 935-939.
|
| [28] |
Knosp E, Steiner E, Kitz K, et al. Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings[J]. Neurosurgery, 1993, 33(4): 610-617.
|
| [29] |
Nishioka H, Fukuhara N, Horiguchi K, et al. Aggressive transsphenoidal resection of tumors invading the cavernous sinus in patients with acromegaly: predictive factors, strategies, and outcomes[J]. J Neurosurg, 2014, 121(3): 505-510.
|
| [30] |
王志明,蒲九君,孙彦龙,等. IGF-1和IGF-1R在无功能性垂体腺瘤中的表达及意义[J].第三军医大学学报, 2015, 37(13): 1367-1372.
|
| [31] |
Sanchez-Tejada L, Sanchez-Ortiga R, Moreno-Perez O, et al. Pituitary tumor transforming gene and insulin-like growth factor 1 receptor expression and immunohistochemical measurement of Ki-67 as potential prognostic markers of pituitary tumors aggressiveness[J]. Endocrinol Nutr, 2013, 60(7): 358-367.
|
| [32] |
Wang H, Tang C, Na M, et al. miR-422a inhibits glioma poliferation and invasion by targeting IGF1 and IGF1R[J]. Oncol Res, 2017, 25(2): 187-194.
|
| [33] |
Gallagher EJ, LeRoith D. World leaders describe the latest in IGF research[J]. J Mol Endocrinol, 2018, 61(1): E1-E3.
|
| [34] |
Yamashita S, Weiss M, Melmed S. Insulin-like growth factor I regulates growth hormone secretion and messenger ribonucleic acid levels in human pituitary tumor cells[J]. J Clin Endocrinol Metab, 1986, 63(3): 730-735.
|
| [35] |
Argente J, Chowen JA, Perez-Jurado LA, et al. One level up: abnormal proteolytic regulation of IGF activity plays a role in human pathophysiology[J]. EMBO Mol Med, 2017, 9(10): 1338-1345.
|
| [36] |
Iguchi H, Nishina T, Nogami N, et al. Phase I dose-escalation study evaluating safety, tolerability and pharmacokinetics of MEDI-573, a dual IGF-I/II neutralizing antibody, in Japanese patients with advanced solid tumours[J]. Invest New Drugs, 2015, 33(1): 194-200.
|
| [37] |
Lee HS, Cho HJ, Kwon GT, et al. Kaempferol downregulates insulin-like growth factor-I receptor and ErbB3 signaling in HT-29 human colon cancer cells[J]. J Cancer Prev, 2014, 19(3): 161-169.
|
| [38] |
Nagaraj K, Lapkina-Gendler L, Sarfstein R, et al. Identification of thioredoxin-interacting protein (TXNIP) as a downstream target for IGF1[J]. Proc Natl Acad Sci USA, 2018, 115(5): 1045-1050.
|
| [39] |
Sanchez-Lopez E, Flashner-Abramson E, Shalapour S, et al. Targeting colorectal cancer via its microenvironment by inhibiting IGF-1 receptor-insulin receptor substrate and STAT3 signaling[J]. Oncogene, 2016, 35(20): 2634-2644.
|
| [40] |
中华医学会神经外科学分会,中国垂体腺瘤协作组,中华医学会内分泌学分会.中国肢端肥大症诊治指南(2013)[J].中华神经外科杂志, 2013, 29(10): 975-979.
|
| [41] |
中国垂体腺瘤协作组.中国垂体腺瘤外科治疗专家共识[J].中华医学杂志, 2015, 95(5): 324-329.
|